Are you Dr. Spitler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Stanyan St
Norther California Melanoma Center St. Mary's Med Cente
San Francisco, CA 94117Phone+1 415-750-5660Fax+1 415-750-4860- Is this information wrong?
Summary
- Dr. Lynn Spitler, MD is an allergist/immunologist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with St. Mary's Medical Center.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1967 - 1969- University of California (San Francisco)Residency, Internal Medicine, 1964 - 1966
Alameda Health System-Highland HospitalInternship, Transitional Year, 1963 - 1964
University of Michigan Medical SchoolClass of 1963- University of California (San Francisco)Fellowship, Ocular Immunology/Uveitis
Certifications & Licensure
CA State Medical License 1964 - 2018- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery Start of enrollment: 1999 Dec 01
- Temodar and Sutent as Therapy for Melanoma Start of enrollment: 2006 Mar 01
- GM-CSF as Adjuvant Therapy of Melanoma Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsClinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.Robert H.I. Andtbacka, Brendan D. Curti, Gregory A. Daniels, Sigrun Hallmeyer, Eric D. Whitman, Jose Lutzky, Lynn E. Spitler, Karl Zhou, Praveen K. Bommareddy, Mark Gr...> ;Journal of Clinical Oncology. 2021 Aug 31
- 39 citationsA phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.Patrick A. Ott, Anna C. Pavlick, Douglas B. Johnson, Lowell L. Hart, Jeffrey R. Infante, Jason J. Luke, Jose Lutzky, Neal Evan Rothschild, Lynn E. Spitler, C. Lance Co...> ;Cancer. 2019 Apr 1
- 6 citationsBiological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Ther...Lynn E Spitler, Huynh Cao, Timo Piironen, Theresa L Whiteside, Robert W. Weber, Scott Cruickshank> ;American Journal of Clinical Oncology. 2017 Apr 1
- Join now to see all
Press Mentions
Edmond ‘Ted’ Eger, Pioneering Anesthesiologist, DiesOctober 6th, 2017
Professional Memberships
- Member
Hospital Affiliations
St. Mary's Medical CenterSan Francisco, California
